Redmile Group’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
BCLSI
FAM
Redmile Group's CABA Position: Q4 2024 in Review
Redmile Group sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 442,826 shares — an estimated $2.09M sold.
Redmile Group first reported a position in CABA in Q4 2019 and held it in 20 quarters. The position peaked at $31.2M in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.
- Redmile Group reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
- Redmile Group sold 442,826 Cabaletta Bio shares in Q4 2024, an estimated $2.09M.
- Redmile Group first reported a position in Cabaletta Bio in Q4 2019 and held it in 20 quarters.
- Redmile Group's Cabaletta Bio position peaked at $31.2M in Q4 2023.
- 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.
Based on Redmile Group's 13F filing for Q4 2024, filed 14 Feb 2025.